Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675855 · ClinicalTrials.gov registry record · Phase 4
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
A Phase 4 study, sponsored by Osiris Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT02675855 is a Phase 4 study that has completed, run by Osiris Therapeutics. The registered enrollment target is 75 participants.
The verdict
NCT02675855, a Phase 4 study, has completed, sponsored by Osiris Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
The objective of the study is to compare the efficacy of weekly GrafixPRIME® administration to an Active Comparator in patients with chronic DFUs in a randomized, single-blind study.
Interventions
- PROCEDURE Dressing Application
- OTHER GrafixPRIME®
- DEVICE Off-loading (walking boot)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02675855
The ClinicalTrials.gov registry entry for NCT02675855 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Osiris Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dressing Application is the first listed.
NCT02675855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02675855 about?
NCT02675855 is a clinical study titled "GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers". The objective of the study is to compare the efficacy of weekly GrafixPRIME® administration to an Active Comparator in patients with chronic DFUs in a randomized, single-blind study.
What is the current status of trial NCT02675855?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2016-01. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02675855?
The interventions under investigation include: Dressing Application (PROCEDURE), GrafixPRIME® (OTHER), Off-loading (walking boot) (DEVICE).
Who is sponsoring clinical trial NCT02675855?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.